Page last updated: 2024-10-18

kynurenine and DDPAC

kynurenine has been researched along with DDPAC in 1 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Research Excerpts

ExcerptRelevanceReference
"Exploring the neurochemical continuum between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) with respect to monoamines and kynurenines in cerebrospinal fluid (CSF) and serum, may be useful to identify possible new research/therapeutic targets."3.96Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum. ( De Deyn, PP; Janssens, J; Kema, IP; van der Ley, C; van Faassen, M; Vermeiren, Y, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Janssens, J1
Vermeiren, Y1
van Faassen, M1
van der Ley, C1
Kema, IP1
De Deyn, PP1

Other Studies

1 other study available for kynurenine and DDPAC

ArticleYear
Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum.
    Neurochemical research, 2020, Volume: 45, Issue:5

    Topics: Aged; Amyotrophic Lateral Sclerosis; Biogenic Monoamines; Biomarkers; Female; Frontotemporal Dementi

2020